Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 199

1.

Preoperative dynamic contrast-enhanced MRI correlates with molecular markers of hypoxia and vascularity in specific areas of intratumoral microenvironment and is predictive of patient outcome.

Jensen RL, Mumert ML, Gillespie DL, Kinney AY, Schabel MC, Salzman KL.

Neuro Oncol. 2014 Jan;16(2):280-91. doi: 10.1093/neuonc/not148. Epub 2013 Dec 4.

2.

Antiangiogenic therapy for primary liver cancer: correlation of changes in dynamic contrast-enhanced magnetic resonance imaging with tissue hypoxia markers and clinical response.

Yopp AC, Schwartz LH, Kemeny N, Gultekin DH, Gönen M, Bamboat Z, Shia J, Haviland D, D'Angelica MI, Fong Y, DeMatteo RP, Allen PJ, Jarnagin WR.

Ann Surg Oncol. 2011 Aug;18(8):2192-9. doi: 10.1245/s10434-011-1570-1. Epub 2011 Feb 1.

3.

Predicting outcomes of patients with intracranial meningiomas using molecular markers of hypoxia, vascularity, and proliferation.

Jensen R, Lee J.

Neurosurgery. 2012 Jul;71(1):146-56. doi: 10.1227/NEU.0b013e3182567886.

PMID:
22472549
4.

Discriminant analysis to classify glioma grading using dynamic contrast-enhanced MRI and immunohistochemical markers.

Awasthi R, Rathore RK, Soni P, Sahoo P, Awasthi A, Husain N, Behari S, Singh RK, Pandey CM, Gupta RK.

Neuroradiology. 2012 Mar;54(3):205-13. doi: 10.1007/s00234-011-0874-y. Epub 2011 May 4.

PMID:
21541688
5.

Dynamic contrast-enhanced magnetic resonance imaging is a poor measure of rectal cancer angiogenesis.

Atkin G, Taylor NJ, Daley FM, Stirling JJ, Richman P, Glynne-Jones R, d'Arcy JA, Collins DJ, Padhani AR.

Br J Surg. 2006 Aug;93(8):992-1000.

PMID:
16673354
6.

Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?

Weber MA, Henze M, Tüttenberg J, Stieltjes B, Meissner M, Zimmer F, Burkholder I, Kroll A, Combs SE, Vogt-Schaden M, Giesel FL, Zoubaa S, Haberkorn U, Kauczor HU, Essig M.

Invest Radiol. 2010 Dec;45(12):755-68. doi: 10.1097/RLI.0b013e3181ec9db0.

PMID:
20829706
7.

AQP-4 in peritumoral edematous tissue is correlated with the degree of glioma and with expression of VEGF and HIF-alpha.

Mou K, Chen M, Mao Q, Wang P, Ni R, Xia X, Liu Y.

J Neurooncol. 2010 Dec;100(3):375-83. doi: 10.1007/s11060-010-0205-x. Epub 2010 May 14.

PMID:
20467785
8.

Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging in patients with rectal cancer: correlation with microvascular density and vascular endothelial growth factor expression.

Kim YE, Lim JS, Choi J, Kim D, Myoung S, Kim MJ, Kim KW.

Korean J Radiol. 2013 Nov-Dec;14(6):878-85. doi: 10.3348/kjr.2013.14.6.878. Epub 2013 Nov 5.

9.

Tumor Vascularity in Renal Masses: Correlation of Arterial Spin-Labeled and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Assessments.

Zhang Y, Kapur P, Yuan Q, Xi Y, Carvo I, Signoretti S, Dimitrov I, Cadeddu JA, Margulis V, Muradyan N, Brugarolas J, Madhuranthakam AJ, Pedrosa I.

Clin Genitourin Cancer. 2016 Feb;14(1):e25-36. doi: 10.1016/j.clgc.2015.08.007. Epub 2015 Aug 29.

10.

Operable non-small cell lung cancer: correlation of volumetric helical dynamic contrast-enhanced CT parameters with immunohistochemical markers of tumor hypoxia.

Mandeville HC, Ng QS, Daley FM, Barber PR, Pierce G, Finch J, Burke M, Bell A, Townsend ER, Kozarski R, Vojnovic B, Hoskin PJ, Goh V.

Radiology. 2012 Aug;264(2):581-9. doi: 10.1148/radiol.12111505. Epub 2012 Jun 14.

PMID:
22700554
11.

PTK787/ZK222584, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor, reduces uptake of the contrast agent GdDOTA by murine orthotopic B16/BL6 melanoma tumours and inhibits their growth in vivo.

Rudin M, McSheehy PM, Allegrini PR, Rausch M, Baumann D, Becquet M, Brecht K, Brueggen J, Ferretti S, Schaeffer F, Schnell C, Wood J.

NMR Biomed. 2005 Aug;18(5):308-21.

PMID:
15918178
12.

RNA interference targeting hypoxia-inducible factor 1α via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model.

Gillespie DL, Aguirre MT, Ravichandran S, Leishman LL, Berrondo C, Gamboa JT, Wang L, King R, Wang X, Tan M, Malamas A, Lu ZR, Jensen RL.

J Neurosurg. 2015 Feb;122(2):331-41. doi: 10.3171/2014.10.JNS132363. Epub 2014 Nov 28.

PMID:
25423275
13.

Correlation of a priori DCE-MRI and (1)H-MRS data with molecular markers in neck nodal metastases: Initial analysis.

Jansen JF, Carlson DL, Lu Y, Stambuk HE, Moreira AL, Singh B, Patel SG, Kraus DH, Wong RJ, Shaha AR, Shah JP, Shukla-Dave A.

Oral Oncol. 2012 Aug;48(8):717-22. doi: 10.1016/j.oraloncology.2012.02.001. Epub 2012 Feb 25.

14.

Necrosis degree displayed in computed tomography images correlated with hypoxia and angiogenesis in breast cancer.

Shan X, Wang D, Chen J, Xiao X, Jiang Y, Wang Y, Fan Y.

J Comput Assist Tomogr. 2013 Jan-Feb;37(1):22-8. doi: 10.1097/RCT.0b013e318279abd1.

PMID:
23321829
15.

Hypoxia-regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme.

Flynn JR, Wang L, Gillespie DL, Stoddard GJ, Reid JK, Owens J, Ellsworth GB, Salzman KL, Kinney AY, Jensen RL.

Cancer. 2008 Sep 1;113(5):1032-42. doi: 10.1002/cncr.23678.

16.

Dynamic contrast-enhanced MRI of gastric cancer: Correlations of the pharmacokinetic parameters with histological type, Lauren classification, and angiogenesis.

Ma L, Xu X, Zhang M, Zheng S, Zhang B, Zhang W, Wang P.

Magn Reson Imaging. 2017 Apr;37:27-32. doi: 10.1016/j.mri.2016.11.004. Epub 2016 Nov 11.

PMID:
27840273
17.

Vascular biomarkers derived from dynamic contrast-enhanced MRI predict response of vestibular schwannoma to antiangiogenic therapy in type 2 neurofibromatosis.

Li KL, Djoukhadar I, Zhu X, Zhao S, Lloyd S, McCabe M, McBain C, Evans DG, Jackson A.

Neuro Oncol. 2016 Feb;18(2):275-82. doi: 10.1093/neuonc/nov168. Epub 2015 Aug 26.

18.

Noninvasive monitoring of radiotherapy-induced microvascular changes using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in a colorectal tumor model.

Ceelen W, Smeets P, Backes W, Van Damme N, Boterberg T, Demetter P, Bouckenooghe I, De Visschere M, Peeters M, Pattyn P.

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1188-96. Epub 2006 Feb 2.

PMID:
16457965
19.

AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.

Wilmes LJ, Pallavicini MG, Fleming LM, Gibbs J, Wang D, Li KL, Partridge SC, Henry RG, Shalinsky DR, Hu-Lowe D, Park JW, McShane TM, Lu Y, Brasch RC, Hylton NM.

Magn Reson Imaging. 2007 Apr;25(3):319-27. Epub 2007 Feb 5.

PMID:
17371720
20.

Connective tissue of cervical carcinoma xenografts: associations with tumor hypoxia and interstitial fluid pressure and its assessment by DCE-MRI and DW-MRI.

Hompland T, Ellingsen C, Galappathi K, Rofstad EK.

Acta Oncol. 2014 Jan;53(1):6-15. doi: 10.3109/0284186X.2013.773073. Epub 2013 Feb 27.

PMID:
23445339

Supplemental Content

Support Center